When did European Biotech Acquisition IPO?

European Biotech Acquisition (EBACU) raised $100 million in an initial public offering (IPO) on Tuesday, March 16th 2021. The company issued 10,000,000 shares at $10.00 per share. Credit Suisse and Kempen & Co. acted as the underwriters for the IPO.

NASDAQ:EBACU

European Biotech Acquisition (EBACU) Stock Price, News & Analysis

→ Your Next Portfolio Star: Revealing 2024's Top Stock Pick (From Darwin) (Ad)

Free EBACU Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: $10.31
▼
$11.97
50-Day Range: $9.75
▼
$10.01
52-Week Range: $9.75
▼
$10.49

Volume: 5,714 shs
Average Volume: 2,500 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get European Biotech Acquisition alerts:

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About European Biotech Acquisition

European Biotech Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in Amsterdam, the Netherlands.

Ad DTI

Start loving Mondays like this

Wouldn’t you love to start looking forward to Mondays? We’re in a New Paradigm Shift in the market that could make it possible! You see, rallies over the weekends have become much more common in the last few years. Imagine hitting a few buttons on your phone or laptop to place a quick trade before the weekend hits… And coming back on Monday to what could be extra income sitting in your account… Weekend after weekend!

Weekend after weekend!

EBACU Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive EBACU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for European Biotech Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: N/A
Industry: N/A
Sub-Industry: N/A
Current Symbol: NASDAQ:EBACU
CUSIP: N/A
CIK: 1841258
Web: www.lspvc.com
Phone: 31 20 664 55 00
Fax: N/A
Employees: 2
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

Mr. Eduardo Bravo Fernandez de Araoz (Age 56)
CEO & Director
Mr. Koen Sintnicolaas (Age 33)
CFO & Director

EBACU Stock Analysis - Frequently Asked Questions

When did European Biotech Acquisition IPO?: European Biotech Acquisition (EBACU) raised $100 million in an initial public offering (IPO) on Tuesday, March 16th 2021. The company issued 10,000,000 shares at $10.00 per share. Credit Suisse and Kempen & Co. acted as the underwriters for the IPO.

This page (NASDAQ:EBACU) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

European Biotech Acquisition (EBACU) Stock Price, News & Analysis

About European Biotech Acquisition

EBACU Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

EBACU Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info